Register now for the OPEN Health Evidence & Access Virtual Summit
Using high-quality scientific evidence to overcome patient access challenges in today’s market
Why OPEN Health?
We bring together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
We are united as one flexible organization, harnessing the power of the collective to solve complex challenges. Our global team of experts — many with PhD and PharmD degrees — work strategically alongside our client partners in Medical Affairs, Health Economics and Outcomes Research (HEOR), Market Access, and Commercial teams across a wide range of therapy areas.
OPEN Health: Established as many. United as one.
What We Do
Our broad range of specialist expertise across many Centers of Excellence allows our clients the flexibility to work with one expert team or to harness the power of the collective to solve complex challenges.
Latest News and Views
Disruptive Listening to Better Engage Patients in Research
Highlights from the Patients as Partners Europe Virtual Conference
Patient Engagement in Health Technology Assessment – Practices and Principles for Europe & the United States – Report Now Available
Patient Engagement in Health Technology Assessment – Report Now Available
The Proper Order of Things is Often A Mystery: A Novel Approach to Selecting Treatment Sequences
Watch the recording of the ISPOR webinar
Solving pharma’s biggest challenges
People are at the heart of our business. Without our incredibly talented people, we couldn’t offer our clients the world-class service they have come to expect.
We know how important it is to support, develop, reward and encourage our team. And that’s just part of what makes OPEN Health a great place to work.
Latest News
A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa
A systematic literature review of the disease burden
Impact of carbidopa-levodopa enteral suspension on quality of life and activities of daily living in patients with advanced Parkinson’s disease: Results from a pooled meta-analysis
Impact of carbidopa-levodopa enteral suspension on quality of
Budget Impact Analysis of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Event
Budget Impact Analysis of Vericiguat for the Treatment